机构:[1]Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China[2]Department of General Surgery, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, China[3]The Second Department of General Surgery, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei Province, China临床科室外二科河北医科大学第四医院[4]Department of Colorectal and Anal Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China[5]Department of Colorectal Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China[6]Department of General Surgery, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China
National
Natural Science Foundation of China (82072678) (J.X.); Clinical
Research Project of Health Professions of Shanghai Municipal
Health Commission (20214Y0277) (W.T.).
第一作者机构:[1]Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Xu Yuqiu,Wang Guiying,Zheng Xuzhi,et al.Treatment of metastatic colorectal cancer with BRAF V600E mutation: A multicenter real-world study in China[J].EJSO.2023,49(11):doi:10.1016/j.ejso.2023.07.007.
APA:
Xu Yuqiu,Wang Guiying,Zheng Xuzhi,Chang Wenju,Fu Jihong...&Xu Jianmin.(2023).Treatment of metastatic colorectal cancer with BRAF V600E mutation: A multicenter real-world study in China.EJSO,49,(11)
MLA:
Xu Yuqiu,et al."Treatment of metastatic colorectal cancer with BRAF V600E mutation: A multicenter real-world study in China".EJSO 49..11(2023)